Amarin to Present at the Jefferies 2015 Global Healthcare Conference

BEDMINSTER, NJ and DUBLIN, IRELAND -- (Marketwired) -- 05/26/15 -- Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that John F. Thero, Amarin's President and Chief Executive Officer, is scheduled to present a general company update at the Jefferies 2015 Global Healthcare Conference on Tuesday, June 2, 2015, at 8:00 a.m. ET.

A live audio webcast of the presentation will be available at:

http://wsw.com/webcast/jeff88/amrn/

About Amarin

Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Amarin's clinical program includes commitment to an ongoing cardiovascular outcomes study. Amarin's first product, Vascepa® (icosapent ethyl) capsules, is a highly pure EPA omega-3 prescription product. For more information about Vascepa visit www.vascepa.com. For more information about Amarin visit www.amarincorp.com.

   Amarin contact informationInvestor RelationsMichael Farrell  Investor Relations and Corporate Communications Amarin Corporation plc In U.S.: +1 (908) [email protected] Morrell Trout Group   In U.S.: +1 (646) [email protected] InquiriesLee Davies Makovsky In U.S.: +1 (212) [email protected]

Source: Amarin Corp. Plc

You May Also Be Interested In

• Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
• PATTISON Modernizes its Out-of-Home Technology Stack with Broadsign
• Tri Pointe Homes, Inc. Reports 2024 First Quarter Results